Boston Scientific

BSX · NYSE

$45.58+$0.53 (+1.18%)TodayMarket closed · Oct 20, 7:56 PM ET

Prev close $45.05

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 59,000 full-time employees. The firm's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Employees: 59,000
Headquarters: Marlborough, Massachusetts
Listed: May 19, 1992
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: bostonscientific.com

Leadership

Boston Scientific executives
Name	Title	Since	Age
Michael Mahoney	—	2011	60
Jonathan Monson	—	—	51
Miriam O' Sullivan	—	—	44
Arthur Butcher	—	—	54
Joseph Fitzgerald	—	—	61
Jeffrey Mirviss	—	—	59
John Sorenson	—	—	57
Vance Brown	—	—	55
Michael Jones	—	—	—
Scott Olson	—	—	54
Meghan Scanlon	—	—	52
Edward Ludwig	—	—	73
Yoshiaki Fujimori	—	—	74
David Habiger	—	—	56
Jessica Mega	—	—	50
Susan Morano	—	—	60
Cheryl Pegus	—	—	61
John Sununu	—	—	60
David Wichmann	—	—	62
Ellen Zane	—	—	73

Revenue by product and region

Fiscal year ended Dec 31, 2019: $10.73B total revenue

By product

Global Interventional Cardiology (IC) Reporting Unit [Member]$2.82B26.2%
Global CRM Reporting Unit [Member]$1.94B18.1%
Global Endoscopy (Endo) Reporting Unit [Member]$1.89B17.6%
Global Urology and Pelvic Health Reporting Unit [Member]$1.41B13.2%
Global Peripheral Interventions (PI) Reporting Unit [Member]$1.39B13.0%
Other$1.21B11.3%

By region

United States [Member]$6.10B56.8%
Non-US [Member]$4.57B42.6%
EMEA [Member]$2.26B21.1%
Asia Pacific [Member]$1.90B17.7%
Emerging Markets [Member]$1.25B11.7%
Latin America and Canada [Member]$395.00M3.7%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Boston Scientific suppliers and customers
Company	Relationship	Country	Correlation
YETI Holdings YETI	Supplier	—	0.83
SurModics SRDX	Supplier and customer	—	0.81
Johnson & Johnson JNJ	Customer	—	0.79
Lisi FII.PA	Supplier	—	0.78
Members	Supplier	—	0.78
Nolato B	Supplier	—	0.76
Sanritsu Corporation	Supplier	—	0.75
Rimoni Industries Ltd. RIMO.TA	Supplier	—	0.75
Integer Holdings ITGR	Supplier	—	0.74
Aamal Company Q.P.S.C. AHCS.QA	Customer	—	0.74

Similar companies

Companies in the same industry as Boston Scientific

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.